Athira Pharma, Inc. (ATHA)
USD 0.54
(-7.41%)
USD 0.54
(-7.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -100.75 Million | -72.46 Million | -43.09 Million | -24.11 Million | -3.71 Million | -4.48 Million |
| Net Income | -117.67 Million | -95.63 Million | -54.85 Million | -19.95 Million | -5.16 Million | -5.09 Million |
| Depreciation & Amortization | 969 Thousand | 845 Thousand | 479 Thousand | 251 Thousand | 2.00 | - |
| Deferred income taxes | -11.85 Thousand | - | - | -251 Thousand | -2.00 | - |
| Stock-based compensation | 10.62 Million | 10.6 Million | 4.62 Million | 633 Thousand | 253 Thousand | 196 Thousand |
| Change in working capital | 6.52 Million | 11.93 Million | 6.16 Million | -6.44 Million | 678 Thousand | 245 Thousand |
| Other non-cash items | -1.18 Million | -219 Thousand | 493 Thousand | 1.65 Million | 517 Thousand | 173 Thousand |
| Investing Cash Flow | 95.08 Million | 57.66 Million | -4.07 Million | -210.06 Million | 1.5 Million | 2 Million |
| Investments in PPE | -304 Thousand | -1.14 Million | -1.57 Million | -2.32 Million | - | - |
| Acquisitions | -95.39 Million | -58.8 Thousand | 2506.00 | - | - | - |
| Investment purchases | -27.67 Million | -95.28 Million | -299.19 Million | -226.83 Million | -995 Thousand | -5.25 Million |
| Sales/Maturities of investments | 123.06 Million | 154.09 Million | 296.69 Million | 19.05 Million | 2.49 Million | 7.25 Million |
| Other Investing Activities | 95.39 Million | 58.8 Thousand | -2506.00 | 36 Thousand | 6000.00 | 7000.00 |
| Financing Cash Flow | 493 Thousand | 654 Thousand | 97.08 Million | 292.75 Million | 946 Thousand | 1.46 Million |
| Debt repayment | - | - | - | -1.66 Million | -874 Thousand | -1.35 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 493 Thousand | 654 Thousand | 96.76 Million | 208.51 Million | 72 Thousand | 112 Thousand |
| Other Financing Activities | 493.00 | 654.00 | 327 Thousand | 85.89 Million | 1.74 Million | 1.46 Million |
| Accounts receivables | -401 Thousand | 1.1 Million | -1.03 Million | -1300.00 | -23.00 | - |
| Accounts payables | 7.36 Million | 2.1 Million | 5.15 Million | 2.6 Million | 701 Thousand | 291 Thousand |
| Inventory | - | -1.1 Million | 1.03 Million | 1300.00 | 23.00 | - |
| Other working capital | -439 Thousand | 9.83 Million | 1.01 Million | -9.04 Million | -23 Thousand | 245 Thousand |
| Cash at beginning of period | 95.96 Million | 110.53 Million | 60.62 Million | 2.05 Million | 3.31 Million | 4.32 Million |
| Cash at end of period | 90.58 Million | 96.38 Million | 110.53 Million | 60.62 Million | 2.05 Million | 3.31 Million |
| Capital Expenditure | -304 Thousand | -1.14 Million | -1.57 Million | -2.32 Million | - | - |
| Effect of forex changes on cash | 5.16 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -5.38 Million | -14.15 Million | 49.91 Million | 58.56 Million | -1.26 Million | -1.01 Million |
| Free Cash Flow | -101.05 Million | -73.61 Million | -44.67 Million | -26.43 Million | -3.71 Million | -4.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.85 Million | -26.33 Million | -27.28 Million | -117.67 Million | -32.97 Million | -29.59 Million |
| Depreciation & Amortization | 242 Thousand | 242 Thousand | 245 Thousand | 969 Thousand | 244 Thousand | 244 Thousand |
| Deferred income taxes | - | - | -4.13 Million | -11.85 Thousand | -394 Thousand | -406 Thousand |
| Stock-based compensation | 3.2 Million | 2.67 Million | 2.22 Million | 10.62 Million | 2.49 Million | 3.11 Million |
| Change in working capital | 1.18 Million | -2.18 Million | -1.25 Million | 6.52 Million | 6.58 Million | 2.3 Million |
| Other non-cash items | 2.29 Million | 6.21 Million | 3.91 Million | -1.18 Million | 54 Thousand | 53 Thousand |
| Investing Cash Flow | 26.56 Million | 13.04 Million | 6.39 Million | 95.08 Million | 20.69 Million | 32.48 Million |
| Investments in PPE | -28 Thousand | -5000.00 | - | -304 Thousand | -30 Thousand | -33 Thousand |
| Acquisitions | - | - | 89 Thousand | -95.39 Million | -20.72 Thousand | -32.51 Thousand |
| Investment purchases | -5.41 Million | -5.91 Million | - | -27.67 Million | -2.78 Million | -15.17 Million |
| Sales/Maturities of investments | 32 Million | 18.95 Million | 6.39 Million | 123.06 Million | 23.5 Million | 47.69 Million |
| Other Investing Activities | 26.59 Million | 13.04 Million | 6391.00 | 95.39 Million | 20.72 Thousand | 32.51 Thousand |
| Financing Cash Flow | 148 Thousand | - | 152 Thousand | 493 Thousand | - | 242 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 148 Thousand | - | 152 Thousand | 493 Thousand | - | 242 Thousand |
| Other Financing Activities | 148 Thousand | - | 152.00 | 493.00 | - | 242.00 |
| Accounts receivables | - | - | -1.62 Million | -401 Thousand | - | - |
| Accounts payables | 1.29 Million | -3.25 Million | 208 Thousand | 7.36 Million | 6.94 Million | 1.5 Million |
| Inventory | - | - | 2.33 Million | - | - | - |
| Other working capital | -105 Thousand | 1.06 Million | 166 Thousand | -439 Thousand | -361 Thousand | 803 Thousand |
| Cash at beginning of period | 77.82 Million | 90.58 Million | 110.33 Million | 95.96 Million | 114.25 Million | 105.81 Million |
| Cash at end of period | 82.2 Million | 77.82 Million | 90.58 Million | 90.58 Million | 110.96 Million | 114.25 Million |
| Capital Expenditure | -28 Thousand | -5000.00 | - | -304 Thousand | -30 Thousand | -33 Thousand |
| Effect of forex changes on cash | - | - | 19.73 Million | 5.16 Million | - | -5.32 Million |
| Net cash flow / Change in cash | 4.38 Million | -12.76 Million | -19.75 Million | -5.38 Million | -3.29 Million | 8.44 Million |
| Free Cash Flow | -22.35 Million | -25.8 Million | -26.29 Million | -101.05 Million | -24.01 Million | -24.31 Million |
TTB
1161
JR
NUSA
4863
BCKIY